Stephen Eeden to Risk Assessment
This is a "connection" page, showing publications Stephen Eeden has written about Risk Assessment.
Connection Strength
0.920
-
Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes. Diabetes Care. 2013 Dec; 36(12):3953-60.
Score: 0.163
-
Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer. J Urol. 2021 Apr; 205(4):1047-1054.
Score: 0.067
-
Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment. Cancer Med. 2020 11; 9(22):8530-8539.
Score: 0.066
-
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality. Urology. 2018 Sep; 119:70-78.
Score: 0.056
-
The Relationship Between Nonsteroidal Anti-inflammatory Drug Use and Age-related Macular Degeneration. Am J Ophthalmol. 2018 04; 188:111-122.
Score: 0.055
-
Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance. BMC Cancer. 2018 01 02; 18(1):2.
Score: 0.054
-
A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease. Eur Urol. 2018 01; 73(1):129-138.
Score: 0.053
-
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clin Proc. 2016 Dec; 91(12):1717-1726.
Score: 0.050
-
A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors. JAMA. 2012 Oct 24; 308(16):1629-31.
Score: 0.038
-
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012 Mar 03; 379(9818):823-32.
Score: 0.036
-
Parturition events and risk of urinary incontinence in later life. Neurourol Urodyn. 2011 Nov; 30(8):1456-61.
Score: 0.035
-
Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. J Neurol Sci. 2011 Aug 15; 307(1-2):22-9.
Score: 0.035
-
Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
Score: 0.033
-
Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Liver Cancer Among Postmenopausal Women. Hepatology. 2020 08; 72(2):535-547.
Score: 0.033
-
Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler. 2010 Jul; 16(7):855-61.
Score: 0.032
-
Pelvic floor disorders and quality of life in women with self-reported irritable bowel syndrome. Aliment Pharmacol Ther. 2010 Feb 01; 31(3):424-31.
Score: 0.031
-
Sexual activity and function in middle-aged and older women. Obstet Gynecol. 2006 Apr; 107(4):755-64.
Score: 0.024
-
Ectopic pregnancy rate and treatment utilization in a large managed care organization. Obstet Gynecol. 2005 May; 105(5 Pt 1):1052-7.
Score: 0.023
-
Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst. 2014 Mar; 106(3):djt465.
Score: 0.021
-
Effect of sexually transmitted infections, lifetime sexual partner count, and recreational drug use on lower urinary tract symptoms in men who have sex with men. Urology. 2012 Jan; 79(1):188-93.
Score: 0.018